NEUROPHARMACEUTICAL MARKET IN USA

25 April 1993

The pharmaceutical industry in Nigeria originated in the early 1970s in conjunction with the crude-oil boom, which provided the impetus for a functioning domestic pharmaceutical industry.

The industry received a substantial fillip in the mid-1970s through to the 1980s from the import substitution policy of the Nigerian government, which sought to rapidly industrialize the country by reducing its dependence on imported drugs. These policies persuaded many pharmaceutical companies over this period that it would be better to enter into local production than solely to import finished drugs.

In terms of number of companies, the pharmaceutical industry has grown principally over the last two decades. Presently, there are about 134 registered local manufacturers in the country. However, local production of medicines has not kept pace with this expansion due to the lingering problem of low capacity utilization.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight